RIP Kinase-mediated programmed necrosis

yusuke murakami, Maki Kayama, Joan W. Miller, Demetrios Vavvas

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Retinal ganglion cell (RGC) death is the ultimate cause of vision loss in glaucoma. Apoptosis has been thought to be a major form of cell death in various diseases including glaucoma; however, attempts to develop neuroprotective agents that target apoptosis have largely failed. Recent accumulating evidence has shown that non-apoptotic forms of cell death such as necrosis are also regulated by specific molecular machinery, such as those mediated by receptor-interacting protein (RIP) kinases. In this review, we summarize recent advances in our understanding of RIP kinase signaling and its roles in RGC loss. These data suggest that not only apoptosis but also necrosis is involved in RGC death and that combined targeting of these pathways may be an effective strategy for glaucoma.

Original languageEnglish
Title of host publicationNeuroprotection and Neuroregeneration for Retinal Diseases
PublisherSpringer Japan
Pages113-122
Number of pages10
ISBN (Electronic)9784431549659
ISBN (Print)4431549641, 9784431549642
DOIs
Publication statusPublished - May 1 2014

Fingerprint

Receptor-Interacting Protein Serine-Threonine Kinases
Protein Kinases
Retinal Ganglion Cells
Cell Death
Necrosis
Glaucoma
Apoptosis
Neuroprotective Agents

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

murakami, Y., Kayama, M., Miller, J. W., & Vavvas, D. (2014). RIP Kinase-mediated programmed necrosis. In Neuroprotection and Neuroregeneration for Retinal Diseases (pp. 113-122). Springer Japan. https://doi.org/10.1007/978-4-431-54965-9_8

RIP Kinase-mediated programmed necrosis. / murakami, yusuke; Kayama, Maki; Miller, Joan W.; Vavvas, Demetrios.

Neuroprotection and Neuroregeneration for Retinal Diseases. Springer Japan, 2014. p. 113-122.

Research output: Chapter in Book/Report/Conference proceedingChapter

murakami, Y, Kayama, M, Miller, JW & Vavvas, D 2014, RIP Kinase-mediated programmed necrosis. in Neuroprotection and Neuroregeneration for Retinal Diseases. Springer Japan, pp. 113-122. https://doi.org/10.1007/978-4-431-54965-9_8
murakami Y, Kayama M, Miller JW, Vavvas D. RIP Kinase-mediated programmed necrosis. In Neuroprotection and Neuroregeneration for Retinal Diseases. Springer Japan. 2014. p. 113-122 https://doi.org/10.1007/978-4-431-54965-9_8
murakami, yusuke ; Kayama, Maki ; Miller, Joan W. ; Vavvas, Demetrios. / RIP Kinase-mediated programmed necrosis. Neuroprotection and Neuroregeneration for Retinal Diseases. Springer Japan, 2014. pp. 113-122
@inbook{dd6d4a7760d64f76aca3c5c06a31115d,
title = "RIP Kinase-mediated programmed necrosis",
abstract = "Retinal ganglion cell (RGC) death is the ultimate cause of vision loss in glaucoma. Apoptosis has been thought to be a major form of cell death in various diseases including glaucoma; however, attempts to develop neuroprotective agents that target apoptosis have largely failed. Recent accumulating evidence has shown that non-apoptotic forms of cell death such as necrosis are also regulated by specific molecular machinery, such as those mediated by receptor-interacting protein (RIP) kinases. In this review, we summarize recent advances in our understanding of RIP kinase signaling and its roles in RGC loss. These data suggest that not only apoptosis but also necrosis is involved in RGC death and that combined targeting of these pathways may be an effective strategy for glaucoma.",
author = "yusuke murakami and Maki Kayama and Miller, {Joan W.} and Demetrios Vavvas",
year = "2014",
month = "5",
day = "1",
doi = "10.1007/978-4-431-54965-9_8",
language = "English",
isbn = "4431549641",
pages = "113--122",
booktitle = "Neuroprotection and Neuroregeneration for Retinal Diseases",
publisher = "Springer Japan",
address = "Japan",

}

TY - CHAP

T1 - RIP Kinase-mediated programmed necrosis

AU - murakami, yusuke

AU - Kayama, Maki

AU - Miller, Joan W.

AU - Vavvas, Demetrios

PY - 2014/5/1

Y1 - 2014/5/1

N2 - Retinal ganglion cell (RGC) death is the ultimate cause of vision loss in glaucoma. Apoptosis has been thought to be a major form of cell death in various diseases including glaucoma; however, attempts to develop neuroprotective agents that target apoptosis have largely failed. Recent accumulating evidence has shown that non-apoptotic forms of cell death such as necrosis are also regulated by specific molecular machinery, such as those mediated by receptor-interacting protein (RIP) kinases. In this review, we summarize recent advances in our understanding of RIP kinase signaling and its roles in RGC loss. These data suggest that not only apoptosis but also necrosis is involved in RGC death and that combined targeting of these pathways may be an effective strategy for glaucoma.

AB - Retinal ganglion cell (RGC) death is the ultimate cause of vision loss in glaucoma. Apoptosis has been thought to be a major form of cell death in various diseases including glaucoma; however, attempts to develop neuroprotective agents that target apoptosis have largely failed. Recent accumulating evidence has shown that non-apoptotic forms of cell death such as necrosis are also regulated by specific molecular machinery, such as those mediated by receptor-interacting protein (RIP) kinases. In this review, we summarize recent advances in our understanding of RIP kinase signaling and its roles in RGC loss. These data suggest that not only apoptosis but also necrosis is involved in RGC death and that combined targeting of these pathways may be an effective strategy for glaucoma.

UR - http://www.scopus.com/inward/record.url?scp=84930736253&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930736253&partnerID=8YFLogxK

U2 - 10.1007/978-4-431-54965-9_8

DO - 10.1007/978-4-431-54965-9_8

M3 - Chapter

AN - SCOPUS:84930736253

SN - 4431549641

SN - 9784431549642

SP - 113

EP - 122

BT - Neuroprotection and Neuroregeneration for Retinal Diseases

PB - Springer Japan

ER -